comparemela.com

Latest Breaking News On - Xponential fitness - Page 1 : comparemela.com

Fund 1 Investments LLC Decreases Stake in Xponential Fitness, Inc. (NYSE:XPOF)

Fund 1 Investments LLC lessened its position in shares of Xponential Fitness, Inc. (NYSE:XPOF – Free Report) by 25.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 17,131 shares of the company’s stock after selling 5,974 shares during the quarter. Fund 1 […]

United-states
America
Piper-sandler
Stifel-nicolaus
Xponential-fitness-inc
Capital-management
Xponential-fitness-company-profile
Kent-lake-capital
Olympiad-research
Citigroup
Club-pilates
Xponential-fitness

The Portnoy Law Firm Announces Investigation of Xponential

The Portnoy Law Firm Announces Investigation of Xponential
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Lesley-portnoy
Lesleyf-portnoy
Portnoy-law-firm
Xponential-fitness-inc
Xponential-fitness

A New Name in Weight Loss Drugs | The Motley Fool

Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.

New-york
United-states
Dylan-lewis
Anthony-geissler
Bloomberg-businessweek
Chris-rondeau
Ricky-mulvey
Sanmeet-deo
Eli-lilly
Barry-mccarthy
Mckesson
Novo-nordisk

Olympiad Research LP Buys Shares of 28,232 Xponential Fitness, Inc. (NYSE:XPOF)

Olympiad Research LP purchased a new stake in shares of Xponential Fitness, Inc. (NYSE:XPOF – Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 28,232 shares of the company’s stock, valued at approximately $364,000. Olympiad Research LP owned about 0.06% of Xponential Fitness at the end […]

United-states
America
Stifel-nicolaus
Robertw-baird
Citigroup
Club-pilates
Xponential-fitness-inc
Quest-partners
Equity-fund
Olympiad-research
Voss-capital
Xponential-fitness

A New Name in Weight Loss Drugs

Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.

New-york
United-states
Sanmeet-deo
Barry-mccarthy
Ricky-mulvey
Bloomberg-businessweek
Dylan-lewis
Chris-rondeau
Eli-lilly
Anthony-geissler
Club-pilates
Nvidia

vimarsana © 2020. All Rights Reserved.